Skip to main content

Antipyretics: Acetaminophen, Arachidonic Acid Agents, and COX1 and COX2 Inhibitors

  • Chapter
  • First Online:
Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care

Abstract

This chapter is intended to provide an overview of fundamentals of nonsteroidal anti-inflammatory drugs (NSAIDs). They are one of the most commonly prescribed medications, with an estimated 70 million number of prescriptions written annually written and $6.8 billion spent worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A. 1999;96:7563–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Bleumink GS, Feenstra J, Sturkenboom MC, Stricker BH. Nonsteroidal anti-inflammatory drugs and heart failure. Drugs. 2003;63:525–34.

    Article  CAS  PubMed  Google Scholar 

  3. Rathmell JP, Fields HL. Chapter 11. Pain: pathophysiology and management. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. http://www.accessmedicine.com/content.aspx?aID=9094544. Accessed 12 Mar 2013.

    Google Scholar 

  4. Grosser T, Smyth E, FitzGerald GA. Goodman & Gilman’s the pharmacological basis of therapeutics, 12e. Section IV. Inflammation, immunomodulation, and hematopoiesis. Chapter 34. Anti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of gout. New York: McGraw-Hill Education, LLC; 2011.

    Google Scholar 

  5. Thorsteinsson SB, Sigvaldason H, Einarsdottir R, et al. Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults-a nationwide registry-based study. Eur J Clin Pharmacol. 2010;66(6):619–25. doi:10.1007/s00228-010-0789-2. Epub 2010 Feb 16. Gudbjornsson Source Centre for Rheumatology Research, Landspitali University Hospital, Reykjavik, Iceland. bjorngu@landspitali.is.

    Article  PubMed  Google Scholar 

  6. Raju N, Sobieraj-Tieague M, Hirsh J, et al. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. MsCc haematology unit, Queensland Pathology and Department of Internal Medicine, Prince Charles Hospital, Brisbane, Australia SA Pathology, Flinders Medical Centre, Adelaide, Australia Thrombosis Medicine, McMaster University, Hamilton.

    Google Scholar 

  7. Furst DE, Ulrich RW, Prakash S. Chapter 36. Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, & drugs used in gout. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic & clinical pharmacology. 12th ed. New York: McGraw-Hill; 2012. http://www.accessmedicine.com/content.aspx?aID=55827134. Accessed 12 Mar 2013.

    Google Scholar 

  8. Wyatt JE, Pettit J, Harirforoosh S. Pharmacogenetics of nonsteroidal anti-inflammatory drugs. Pharmacogenomics J. 2012;12:462–7.

    Article  CAS  PubMed  Google Scholar 

  9. World Health Organization (WHO). National Cancer Control Programmes: policies and managerial guidelines. 3rd ed. Geneva; 2002. Available from: http://whqlibdoc.who.int/hq/2002/9241545577.pdf. Last access on 14 Feb 2013.

  10. Horlocker TT, Wedel DJ, Rowlingson JC, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of regional anesthesia and pain medicine evidence-based guidelines (3rd ed). Reg Anesth Pain Med. 2010;35(1):64–101.

    Article  CAS  PubMed  Google Scholar 

  11. Rosenecher N, Bottet M, Sessler D. Selected new antithrombotic agents and neuraxial anesthesia for major orthopaedic surgery: management strategies. Anaesthesia. 2007;62:1154–60.

    Article  Google Scholar 

  12. Novak E, Allen PJ. Prescribing medications in pediatrics: concerns regarding FDA approval and pharmacokinetics. Pediatr Nurs. 2007;33:64–70.

    PubMed  Google Scholar 

  13. Committee on Infectious Diseases, American Academy of Pediatrics. Pickering LK, editor. 2012. Red Book®: 2012 Report of the Committee on infectious diseases – 29th ed. 2012. Printed in the United States of America. American Academy of Pediatrics. ISBN-10: 1-58110-703-X, ISBN-13: 978-1-58110-703-6. ISSN: 1080-0131. STAT!Ref Online Electronic Medical Library. http://online.statref.com/document.aspx?fxid=76&docid=58. 2/13/2013 4:12:28PM CST (UTC -06:00).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to My Tu MD .

Editor information

Editors and Affiliations

Chemical Structures

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Tu, M., Gritsenko, K., Kosharskyy, B., Shaparin, N. (2015). Antipyretics: Acetaminophen, Arachidonic Acid Agents, and COX1 and COX2 Inhibitors. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8948-1_27

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8947-4

  • Online ISBN: 978-1-4614-8948-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics